← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2023-09-30 · Filed 2023-11-14 · Accession 0001420506-23-002213
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | 89BIO INC | COM · 282559103 | LONG | 1,590,387 | $24.6 million |
| 2 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 967,690 | $5.3 million |
| 3 | AGENUS INC | COM NEW · 00847G705 | LONG | 6,307,030 | $7.1 million |
| 4 | ALECTOR INC | COM · 014442107 | LONG | 4,074,120 | $26.4 million |
| 5 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 125,213 | $38.2 million |
| 6 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 44,750,000 | $43.1 million |
| 7 | ALX ONCOLOGY HLDGS INC | COM · 00166B105 | LONG | 1,249,900 | $6.0 million |
| 8 | AMGEN INC | COM · 031162100 | LONG | 36,200 | $9.7 million |
| 9 | ANAPTYSBIO INC | COM · 032724106 | LONG | 1,049,823 | $18.9 million |
| 10 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 491,113 | $10.5 million |
| 11 | ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 · 04351PAD3 | LONG | 124,000,000 | $113.8 million |
| 12 | AXONICS INC | COM · 05465P101 | LONG | 354,527 | $19.9 million |
| 13 | BICYCLE THERAPEUTICS PLC | SPONSORED ADS · 088786108 | LONG | 1,289,872 | $25.9 million |
| 14 | BIOCRYST PHARMACEUTICALS INC | COM · 09058V103 | LONG | 5,362,980 | $38.0 million |
| 15 | BOSTON SCIENTIFIC CORP | COM · 101137107 | LONG | 1,164,850 | $61.5 million |
| 16 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 114,338,000 | $109.8 million |
| 17 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 67,294,000 | $50.5 million |
| 18 | COMPASS THERAPEUTICS INC | COM · 20454B104 | LONG | 5,954,273 | $11.7 million |
| 19 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 1,908,865 | $17.3 million |
| 20 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 33,900,000 | $20.0 million |
| 21 | DANAHER CORP DEL | COM · 235851102 | LONG | 77,200 | $19.2 million |
| 22 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 3,715,573 | $45.6 million |
| 23 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 12,107,785 | $16.5 million |
| 24 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 3,336,221 | $42.4 million |
| 25 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 37,500,000 | $35.5 million |
| 26 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 1,821,972 | $16.3 million |
| 27 | ENANTA PHARMACEUTICALS INC | COM · 29251M106 | LONG | 1,038,310 | $11.6 million |
| 28 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 131,000,000 | $113.7 million |
| 29 | GLAUKOS CORP | COM · 377322102 | LONG | 695,792 | $52.4 million |
| 30 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 689,000 | $20.4 million |
| 31 | GUARDANT HEALTH INC | NOTE 11/1 · 40131MAB5 | LONG | 268,252,000 | $185.8 million |
| 32 | HARROW INC | COM · 415858109 | LONG | 1,808,684 | $26.0 million |
| 33 | HILLEVAX INC | COM · 43157M102 | LONG | 1,449,246 | $19.5 million |
| 34 | IMMUNOCORE HLDGS PLC | ADS · 45258D105 | LONG | 906,973 | $47.1 million |
| 35 | INCYTE CORP | COM · 45337C102 | LONG | 294,900 | $17.0 million |
| 36 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 39,963,000 | $39.7 million |
| 37 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 100,300 | $19.9 million |
| 38 | INSULET CORP | NOTE 0.375% 9/0 · 45784PAK7 | LONG | 54,500,000 | $53.6 million |
| 39 | INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 · 457985AM1 | LONG | 14,500,000 | $13.3 million |
| 40 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 114,920 | $33.6 million |
| 41 | INVITAE CORP | NOTE 2.000% 9/0 · 46185LAB9 | LONG | 16,781,000 | $14.9 million |
| 42 | IONIS PHARMACEUTICALS INC | NOTE 4/0 · 462222AD2 | LONG | 52,740,000 | $51.8 million |
| 43 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 568,157 | $53.6 million |
| 44 | IRONWOOD PHARMACEUTICALS INC | COM CL A · 46333X108 | LONG | 1,348,099 | $13.0 million |
| 45 | IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 · 46333XAF5 | LONG | 37,509,000 | $37.3 million |
| 46 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 15,500,000 | $15.1 million |
| 47 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $40.9 million |
| 48 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 1,357,309 | $43.3 million |
| 49 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 77,497 | $9.0 million |
| 50 | LANTHEUS HLDGS INC | COM · 516544103 | LONG | 288,300 | $20.0 million |
| 51 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 879,564 | $59.1 million |
| 52 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 3,974,857 | $39.7 million |
| 53 | MERUS N V | COM · N5749R100 | LONG | 1,901,337 | $0 |
| 54 | MINERALYS THERAPEUTICS INC | COM · 603170101 | LONG | 2,023,900 | $19.2 million |
| 55 | NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 · 63009RAD1 | LONG | 145,520,000 | $112.4 million |
| 56 | NATERA INC | COM · 632307104 | LONG | 1,012,145 | $44.8 million |
| 57 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 28,000,000 | $26.3 million |
| 58 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 62,601,000 | $45.2 million |
| 59 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 968,024 | $108.9 million |
| 60 | NEVRO CORP | COM · 64157F103 | LONG | 1,776,368 | $34.1 million |
| 61 | NEVRO CORP | NOTE 2.750% 4/0 · 64157FAC7 | LONG | 109,251,000 | $102.0 million |
| 62 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 135,834,000 | $118.0 million |
| 63 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 61,340,000 | $56.6 million |
| 64 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,057,770 | $33.8 million |
| 65 | OUTSET MED INC | COM · 690145107 | LONG | 2,400,427 | $26.1 million |
| 66 | PARAGON 28 INC | COM · 69913P105 | LONG | 3,361,824 | $42.2 million |
| 67 | PENUMBRA INC | COM · 70975L107 | LONG | 95,315 | $23.1 million |
| 68 | PROCEPT BIOROBOTICS CORP | COM · 74276L105 | LONG | 331,061 | $10.9 million |
| 69 | PROTAGONIST THERAPEUTICS INC | COM · 74366E102 | LONG | 1,109,150 | $18.5 million |
| 70 | PULMONX CORP | COM · 745848101 | LONG | 988,559 | $10.2 million |
| 71 | RAPT THERAPEUTICS INC | COM · 75382E109 | LONG | 1,082,512 | $18.0 million |
| 72 | RAYZEBIO INC | COM · 75525N107 | LONG | 277,778 | $6.2 million |
| 73 | REPLIGEN CORP | COM · 759916109 | LONG | 118,400 | $18.8 million |
| 74 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 487,520 | $8.3 million |
| 75 | SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 · 803607AD2 | LONG | 44,166,000 | $49.5 million |
| 76 | SEAGEN INC | COM · 81181C104 | LONG | 42,497 | $9.0 million |
| 77 | TERNS PHARMACEUTICALS INC | COM · 880881107 | LONG | 2,840,052 | $14.3 million |
| 78 | THE BEAUTY HEALTH COMPANY | COM CL A · 88331L108 | LONG | 1,626,236 | $9.8 million |
| 79 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 75,749 | $38.3 million |
| 80 | THIRD HARMONIC BIO INC | COM · 88427A107 | LONG | 1,653,991 | $10.6 million |
| 81 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 307,200 | $16.8 million |
| 82 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $48.2 million |
| 83 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 28,350,000 | $18.4 million |
| 84 | VAXCYTE INC | COM · 92243G108 | LONG | 1,619,553 | $82.6 million |
| 85 | VIRIDIAN THERAPEUTICS INC | COM · 92790C104 | LONG | 1,735,182 | $26.6 million |
| 86 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 2,103,396 | $71.9 million |